Fiocruz International News - March 2022 - Fundação Oswaldo Cruz (Fiocruz): Ciência e tecnologia em saúde para a população brasileira

If you can't read this, click here

Bimonthly newsletter of the Fiocruz Global Health Center (Cris/Fiocruz)

March / 2022

Fiocruz participates in the Global Pandemic Preparedness Summit

The president of the Foundation, Nísia Trindade Lima, highlighted the need to decentralize vaccine production and reinforce investments in research and development during the event in London

COVID-19: Fiocruz releases first 100% Brazilian vaccine against the disease

The Foundation, through the Immunobiological Technology Institute (Bio-Manguinhos), provides the first doses of the vaccine produced with the national Active Pharmaceutical Ingredient. The first batch was released by the internal quality control on February 14th

Omicron variant accounts for more than 95% of the genomes sequenced in Brazil

The Fiocruz Genomic Network has released new data on the status of lineages and variants of the Sars-CoV-2 in Brazil, based on the genomic surveillance produced by its plataform and other initiatives

Study identifies higher mortality in children with Congenital Zika Syndrome

Research published in "The New England Journal of Medicine" found that children with Congenital Zika Syndrome are up to 11 times more likely to die, when compared to children without it, by their third year of life

International research uses artificial intelligence to accelerate leprosy diagnosis

An international team of scientists, led by the Oswaldo Cruz Institute in partnership with Microsoft AI for Health and the Novartis Foundation, has developed a diagnostic assistant which can help to identify suspected lesions

Article: Reboot biomedical R&D in the global public interest

The authors of the article published in "Nature", including the president of Fiocruz, highlight that COVID-19 has made more evident the inequity in access to the benefits of research and the need to reorient the system

Fiocruz Biorepository will allow complementary studies of the Sars-CoV-2 variants

The initiative, led by the Fiocruz Genomic Network, will allow sharing data with other groups for comparison, neutralization assays and other research purposes

WHO Deputy Director warns at seminar: the pandemic is not over yet

Countries with high vaccination coverage are adopting a dangerous rhetoric according to which the pandemic is over. But how can one state that when there are still 70,000 people dying of COVID-19 in a week, asks Mariângela Simão

During the Mexican consul’s visit to Fiocruz, a promise of more convergence

With joint projects, Mexican institutions and Fiocruz will be able to increase cooperation, suggests consul Héctor Humberto Valezzi Zafra during a visit to the Official Residence of the Foundation

Project points to potential benefit of selenium against Chagas disease

Published on "EClinicalMedicine", the result of the first clinical trial with selenium supplementation for patients with Chagas cardiopathy showed a potential benefit provided by the treatment in at least one subgroup of patients

Ecuador ambassador discusses scientific cooperation with Fiocruz president

Carlos Alberto Velástegui was at Fiocruz to strengthen ties between his country and the Foundation. Welcomed by President Nísia Trindade Lima, he was interested in raising areas for possible cooperation with Ecuadorian institutions

Links relacionados:

Centro de Relações Internacionais em Saúde da Fiocruz

Fiocruz International News
Bimonthly report of the Fiocruz Global Health Center (Cris/Fiocruz), edited by the Fiocruz Coordination of Social Communication

Masthead | cancel subscription

Subscribe to Fiocruz International Newsletter

Subscribe and receive our news via email

Latest Newsletters

Fiocruz International News - March 2024

Fiocruz International News - January 2024

Fiocruz International News - November 2023